Thermo Fisher Scientific

Thermo Fisher Scientific
source
Name	Thermo Fisher Scientific
Type	Public
Traded as	NYSE: TMO
Industry	Biotechnology and Life sciences
Founded	2006
Founder	Henry Nichols and George Wilkins
Headquarters	Waltham, Massachusetts
Key people	Marc Casper and Peter Hornstra

Thermo Fisher Scientific is a leading American Biotechnology company that provides a wide range of products and services for the Life sciences industry, including Genomics, Proteomics, and Cell biology. The company was formed in 2006 through the merger of Thermo Electron and Fisher Scientific, and has since become a major player in the industry, with a strong presence in countries such as United States, China, and India. Thermo Fisher Scientific has a diverse portfolio of products and services, and has collaborated with numerous organizations, including National Institutes of Health and European Organization for Nuclear Research. The company's products and services are used by researchers and scientists at institutions such as Harvard University, Stanford University, and Massachusetts Institute of Technology.

● History

Thermo Fisher Scientific was formed in 2006 through the merger of Thermo Electron and Fisher Scientific, two companies with a long history in the Life sciences industry. Thermo Electron was founded in 1956 by George Wilkins and Henry Nichols, and was initially focused on the development of Thermocouples and other Temperature measurement devices. Fisher Scientific was founded in 1902 by Chester Fisher, and was initially a manufacturer of Laboratory equipment and Scientific instruments. Over the years, both companies expanded their product lines and acquired numerous other companies, including Kendro Laboratory Products and Bran+Luebbe. The merger of Thermo Electron and Fisher Scientific created a company with a diverse portfolio of products and services, and a strong presence in the Life sciences industry, with partnerships with organizations such as American Cancer Society and World Health Organization.

● Products and Services

Thermo Fisher Scientific provides a wide range of products and services for the Life sciences industry, including Genomics, Proteomics, and Cell biology. The company's product portfolio includes Mass spectrometry instruments, such as the Thermo Scientific Orbitrap and Thermo Scientific TSQ, as well as Chromatography systems, such as the Thermo Scientific UltiMate 3000 and Thermo Scientific Vanquish. Thermo Fisher Scientific also offers a range of Laboratory equipment, including Microscopes, Spectrophotometers, and Centrifuges, which are used by researchers and scientists at institutions such as University of California, Berkeley and University of Oxford. The company's services include Contract research and Contract manufacturing, which are provided to companies such as Pfizer and Merck & Co.. Thermo Fisher Scientific has also collaborated with numerous organizations, including National Cancer Institute and European Molecular Biology Laboratory.

● Research and Development

Thermo Fisher Scientific has a strong commitment to Research and development, with a focus on developing new products and technologies for the Life sciences industry. The company has a number of Research centers around the world, including facilities in United States, China, and Germany, which collaborate with institutions such as California Institute of Technology and University of Cambridge. Thermo Fisher Scientific has also partnered with numerous academic and research institutions, including Harvard University and Stanford University, to develop new technologies and products, such as CRISPR and Gene editing. The company's research and development efforts are focused on a number of areas, including Genomics, Proteomics, and Cell biology, and have led to the development of numerous new products and technologies, including the Thermo Scientific Ion Torrent and Thermo Scientific Q Exactive.

● Acquisitions and Partnerships

Thermo Fisher Scientific has made a number of acquisitions and partnerships over the years, which have helped to expand its product portfolio and strengthen its position in the Life sciences industry. In 2010, the company acquired Bran+Luebbe, a manufacturer of Analytical instruments, and in 2011, it acquired Phadia, a manufacturer of Allergy testing equipment. Thermo Fisher Scientific has also partnered with numerous companies, including Illumina and Roche Holding, to develop new products and technologies, such as Next-generation sequencing and Companion diagnostics. The company has also collaborated with numerous academic and research institutions, including National Institutes of Health and European Organization for Nuclear Research, to develop new technologies and products, such as Synthetic biology and Gene therapy.

● Operations and Facilities

Thermo Fisher Scientific has operations and facilities around the world, including in United States, China, and Europe. The company's headquarters are located in Waltham, Massachusetts, and it has a number of manufacturing facilities, including sites in United States, China, and Germany. Thermo Fisher Scientific also has a number of Research centers and Sales offices around the world, which provide support to customers and partners, including institutions such as University of Tokyo and University of Melbourne. The company's operations are managed by a team of experienced executives, including Marc Casper and Peter Hornstra, who have previously worked at companies such as Merck & Co. and Pfizer.

● Financial Information

Thermo Fisher Scientific is a publicly traded company, listed on the NYSE under the ticker symbol TMO. The company's revenue has grown significantly over the years, driven by the acquisition of new companies and the development of new products and technologies. In 2020, Thermo Fisher Scientific reported revenue of over $25 billion, with a net income of over $3 billion. The company's financial performance is closely watched by investors and analysts, who follow the company's progress and provide analysis and commentary on its financial results, including Bloomberg and Forbes. Thermo Fisher Scientific has also been recognized for its financial performance, including being named one of the Fortune 500 companies, and has partnerships with financial institutions such as Goldman Sachs and Morgan Stanley. Category:Biotechnology companies